Selasa, 25 Agustus 2009

WHEN IT COMES TO H1N1 BEING OLD LOOKS LIKE A GOOD THING RECOMMENDATIONS FOR SWINE FLU INFLUENZA A VACCINATION

WHEN IT COMES TO H1N1 BEING OLD LOOKS LIKE A GOOD THING RECOMMENDATIONS FOR SWINE FLU INFLUENZA A VACCINATION




Winston Churchill , when asked how it feels to be old was said to remark that considering the alternative it's not bad. Generally though, it seems that when it comes to disease and health the elderly take a disproportionate hit but perhaps not in the case of the swine influenza A flu H1N1. I was surprised when I read the CDC recommendations about the priority of who should be vaccinated for swine flu H1N1.


"The committee does not expect that there will be a shortage of novel H1N1 vaccine, but availability and demand can be unpredictable. There is some possibility that initially the vaccine will be available in limited quantities. In this setting, the committee recommended that the following groups receive the vaccine before others:



  • pregnant women,
  • people who live with or care for children younger than 6 months of age,
  • health care and emergency medical services personnel with direct patient contact,
  • children 6 months through 4 years of age, and
  • children 5 through 18 years of age who have chronic medical conditions.



    The committee recognized the need to assess supply and demand issues at the local level. The committee further recommended that once the demand for vaccine for these prioritized groups has been met at the local level, programs and providers should begin vaccinating everyone from ages 25 through 64 years. Current studies indicate the risk for infection among persons age 65 or older is less than the risk for younger age groups. Therefore, as vaccine supply and demand for vaccine among younger age groups is being met, programs and providers should offer vaccination to people over the age of 65".

  • CDC Advisors Make Recommendations for Use of Vaccine Against Novel H1N1




    How the Flu Virus Can Change: "Drift" and "Shift"

    Influenza viruses can change in two different ways.


    One is called "antigenic drift." These are small changes in the virus that happen continually over time. Antigenic drift produces new virus strains that may not be recognized by the body's immune system. This process works as follows: a person infected with a particular flu virus strain develops antibody against that virus. As newer virus strains appear, the antibodies against the older strains no longer recognize the "newer" virus, and reinfection can occur. This is one of the main reasons why people can get the flu more than one time. In most years, one or two of the three virus strains in the influenza vaccine are updated to keep up with the changes in the circulating flu viruses. So, people who want to be protected from flu need to get a flu shot every year.



    The other type of change is called "antigenic shift." Antigenic shift is an abrupt, major change in the influenza A viruses, resulting in new hemagglutinin and/or new hemagglutinin and neuraminidase proteins in influenza viruses that infect humans. Shift results in a new influenza A subtype. When shift happens, most people have little or no protection against the new virus. While influenza viruses are changing by antigenic drift all the time, antigenic shift happens only occasionally. Type A viruses undergo both kinds of changes; influenza type B viruses change only by the more gradual process of antigenic drift.



  • All About Flu
  • Rabu, 19 Agustus 2009

    MAKING LEMONS INTO LEMONADE A COMPUTER GLITCH GIVES BIG TIME SCIENTIST IDEA THAT HIGH BLOOD PRESSURE DRUGS MIGHT TREAT MULTIPLE SCLEROSIS

    MAKING LEMONS INTO LEMONADE A COMPUTER GLITCH GIVES BIG TIME SCIENTIST IDEA THAT HIGH BLOOD PRESSURE DRUGS MIGHT TREAT MULTIPLE SCLEROSIS




    What does using a blood pressure drug to treat multiple sclerosis have to do with Louis Pasteur? Pasteur's assistant was about to throw into the garbage samples of bacteria they were using in an experiment. The bacteria usually killed chickens but these didn't harm a feather. Pasteur derailed the garbage plan realizing he was on to something, which turned out to be vaccine. This kind of stuff happens in biology, science and medicine a lot more than you might think. I thought of that when I read the amazing story of how a researcher at Stanford got the idea that blood pressure drugs might have some connection with multiple sclerosis.





    PNAS (Proceedings National Academy of Science) is carrying a paper about the possibility that a blood pressure drug might have the power to treat multiple sclerosis symptoms. The paper showed an effect in mice with MS like disease. "Researchers at the Stanford University School of Medicine have found a link, in mice and in human brain tissue, between high blood pressure and multiple sclerosis. Their findings suggest that a safe,(when used properly) inexpensive drug already in wide use for high blood pressure may have therapeutic value in multiple sclerosis, as well".














    Lisinopril and the class it belongs to, ACE inhibitors, is one of the favorite heart and blood pressure drugs of cardiologists and family practioners. Angiotension Converting enzyme (see why they call them ACE?) inhibitors seem to have added beneficial side effects like heart remodeling.





    "The genesis for the paper can be traced to about seven years ago, when Steinman learned he had high blood pressure. His doctor put him on lisinopril, which is used by millions of people all over the world and has an excellent safety profile. Chagrined, Steinman went home and, researcher that he is, immediately did a Google search on the drug. (Steinman is a renowned multiple sclerosis investigator whose earlier work on the inflammatory features of the disease spurred development of a blockbuster class of anti-inflammatory multiple-sclerosis therapeutics. The drug natalizumab, marketed under the trade name Tysabri, is one).





    "Long ago, a glitch crept into Steinman’s home computer: No matter what keywords he types into the search field, the computer automatically inserts the additional term, “multiple sclerosis.” Thus, to his surprise, a list of medical literature popped up offering tantalizing, if vague, hints of a possible connection between multiple sclerosis and a fast-acting hormone, angiotensin, whose receptors abound on blood-vessel walls throughout the body."












  • Inexpensive hypertension drug could be multiple sclerosis treatment, study shows


  • Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity

  • Steinman Lab page



  • Rabu, 12 Agustus 2009

    BESIDES LOWERING HEART ATTACK RISK ASPIRIN IS ONCE AGAIN SAID TO LESSEN CANCER RISK THIS WEEK ITS COLORECTAL CANCER LIKE COLON CANCER

    BESIDES LOWERING HEART ATTACK RISK ASPIRIN IS ONCE AGAIN SAID TO LESSEN CANCER RISK THIS WEEK ITS COLORECTAL CANCER LIKE COLON CANCER



    I have written before about the numerous reports of aspirin's myriad benefits (but remember there are also risks such as stomach ulcers and asthma exacerbation). Aspirin benefits like possibly reducing the chance of a heart attack or a thrombotic stroke (probably increases chance of brain hemorrhage). The latest in the litany of benefits is the Harvard Med School/Mass General report in the Journal of the American Medical Association saying that "Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer–specific and overall mortality, especially among individuals with tumors that overexpress COX-2". As you can see in the NY Times article, the reason that cancer is lessened is believed to be linked to the expression of an enzyme that is blocked by aspirin, namely cyclooxygenase 2. You'll remember that pharmaceutical companies created a whole class of COX 2 inhibitors that weren't supposed to have aspirin's bleeding side effects but turned out to have their own problems.














  • Aspirin Seen Lowering Colorectal Cancer Risk
  • Aspirin Use and Survival After Diagnosis of Colorectal Cancer "Conclusion: Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer–specific and overall mortality, especially among individuals with tumors that overexpress COX-2".
    Also check out a previous healty medical Blog post, namely
  • ASPIRIN IS GOOD FOR THE HEART BUT HARVARD OXFORD STUDIES SAY ASPIRIN PROTECTS AGAINST COLON AND RECTAL CANCER
  • Official Swine Flu South Africa Stats - 12 August 2009

    Death count... wait for it... 2.



    Some say, a flash in the pan. Others say, this is how it starts.

    We really dunno. SA Doc thinks the pandemonium is a bit OTT (over the top).